Baber N S, Evans D W, Howitt G, Thomas M, Wilson T, Lewis J A, Dawes P M, Handler K, Tuson R
Br Heart J. 1980 Jul;44(1):96-100. doi: 10.1136/hrt.44.1.96.
A multicentre study of survivors of an anterior myocardial infarction is reported. The trial consisted of 720 patients and was a double-blind, placebo-controlled study with propranolol 40 mg three times a day. Trial entry was at two to 14 days (mean 8.5 days) and follow-up at one, three, and in most centres, six and nine months. The trial was designed to detect a 50 per cent reduction in mortality and this was not shown. The non-fatal reinfarction rate was similar in both groups. Subgroup analysis identified several prognostic risk factors for death, none of which interacted with treatment.
本文报道了一项关于前壁心肌梗死幸存者的多中心研究。该试验共有720名患者,是一项双盲、安慰剂对照研究,患者每日三次服用40毫克普萘洛尔。试验入选时间为发病后2至14天(平均8.5天),随访时间为1个月、3个月,多数中心还进行了6个月和9个月的随访。该试验旨在检测死亡率降低50%的效果,但未得到证实。两组的非致命性再梗死率相似。亚组分析确定了几个死亡的预后风险因素,其中没有一个与治疗有相互作用。